RxDoctor Payments Data

Barbara Lowry, MD

Psychiatry · Salisbury, NCNPI 1841374337

Payments from drug & device makers

$5,429in general payments, 2019–2025

Across 346 payments — averaging $15.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$917
  • Otsuka America Pharmaceutical, Inc.$807
  • Sunovion Pharmaceuticals Inc.$602
  • Lundbeck LLC$573
  • Teva Pharmaceuticals USA, Inc.$512
  • Neurocrine Biosciences, Inc.$465
  • plus $2K from 19 others

What the payments were for

  • Food & beverage$5,39899%
  • Education$321%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,429 in reported general payments places this provider in the 85th percentile of 1,108 psychiatry providers in North Carolina.

See all psychiatry providers in North Carolina

Medicare billing

Part B allowed, 2024
$78,928
Medicare patients
121
Services billed
1,137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine23$156,796
RexultiBrexpiprazole66$98,276
VraylarCariprazine Hcl34$47,029
VyvanseLisdexamfetamine Dimesylate34$17,544
TrintellixVortioxetine Hydrobromide18$12,780
Aripiprazole296$10,281
Lamotrigine555$9,216
Venlafaxine Hcl ErVenlafaxine Hcl475$9,008
Desvenlafaxine Succinate ErDesvenlafaxine Succinate191$8,321
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine192$7,561
Bupropion XlBupropion Hcl347$6,409
Duloxetine Hcl246$4,750
Lurasidone Hcl50$4,468
Quetiapine Fumarate328$4,335
Lisdexamfetamine Dimesylate18$4,226

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$512$156,79623 claims
Otsuka America Pharmaceutical, Inc.Rexulti$807$98,27666 claims
AbbVieVraylar$917$47,02934 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse, Trintellix$234$30,32452 claims
Almatica Pharma LLCSertraline Hcl$109$1,680270 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,108 psychiatry providers in North Carolina.

Other psychiatry in Salisbury

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →